PRESIDE A singing study!
12 May 2021
It is well documented that music and singing are beneficial to those living with dementia. Listening to or singing songs can provide both behavioural and emotional benefits and the power of music can unlock memories and help provide links to a person’s past and promote connection with carers. Researchers at Nottingham University are looking for […]
New potential treatment for early-stage Alzheimer’s disease
3 March 2021
Alzheimer’s disease affects approximately 70% of people diagnosed with dementia, and an estimated 26 million people worldwide. In the very early stages, Alzheimer’s disease may be referred to or diagnosed as Mild Cognitive Impairment (MCI). There are no available treatments to prevent or delay the start of Alzheimer’s disease and currently medications only provide a […]
Join us in celebrating 6 years of dementia research
24 February 2021
As we turn six today, we are celebrating not only six years of bringing researchers and volunteers together, but also our collective achievement of helping dementia research to keep going during the pandemic. See what our volunteers, charity partners and researchers have to say about us! Since Join Dementia Research began, an incredible […]
12 February 2021
Retired nurse Joyce signed up to Join Dementia Research when she was diagnosed with Alzheimer’s disease in 2016, aged 75. Having worked as a healthcare professional, she’s always had an interest in research and an appetite for being involved herself. Professional insight During her nursing days, Joyce was trained in how to identify potential symptoms […]
Alzheimer’s drug study restarts
23 November 2020
An Alzheimer’s drug study is restarting after being paused earlier this year. The CLARITY study is examining whether the drug BAN2401 can be effective in preventing or delaying the very early stages of Alzheimer’s disease. Alzheimer’s disease affects approximately 26 million people worldwide and current medications only provide a temporary improvement in symptoms. Who can […]
World Alzheimer’s Day
21 September 2020
This year’s theme for World Alzheimer’s Day is “Let’s Talk About Dementia”, and it’s more important than ever that we continue to advance dementia care and treatments. Research is the best hope to do this. You can see if you are eligible to take part in our studies by registering or logging into Join Dementia Research.
Dementia fears for former footballers
25 October 2019
A recent study has found that the risk of dying from neurodegenerative disease is almost 3.5 times higher for footballers. However research is at an early stage and there’s currently no suggestion that anyone should stop playing football. Regular physical activity – including football – is a good way to reduce the risk of dementia and conditions such as heart disease.
In the news: Potential new drug may slow Alzheimer’s disease
23 October 2019
US pharmaceutical company Biogen has announced that they plan to ask US drug regulators to approve their experimental Alzheimer’s drug, aducanumab. Aducanumab is designed to target amyloid, a protein that builds up in the brains of people with the early stages of Alzheimer’s disease. The announcement follows Phase III clinical trials called ENGAGE and EMERGE. New analysis of trial data has produced promising results – those who received high doses of aducanumab showed significant slowing in the decline of their cognitive ability.
Electromagnetic ‘bathing cap’ shows promise in early Alzheimer’s disease trial
23 September 2019
In a new study, researchers designed a bathing cap-style head device, called the MemorEM, which was used to deliver electromagnetic waves to the brain. The purpose of this was to try to dissolve what are known as oligomers – groups of abnormal proteins – as they were forming. There was some sign of improvements on tests of thinking and memory in most of the people taking part in the study. This is an experimental, early-stage study that looked primarily at safety, so it cannot tell us for sure if the treatment works.
New type of dementia discovered
2 May 2019
Researchers have identified a new form of dementia. Known as LATE, it shares many similarities with Alzheimer’s disease, but tends to lead to a more gradual decline in memory. LATE (limbic-predominant age-related TDP-43 encephalopathy) appears to be linked to the accumulation of a protein called TDP-43 in the brain, whereas Alzheimer’s is linked to the […]